Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells.
Open Access
- 1 June 1993
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 177 (6) , 1541-1550
- https://doi.org/10.1084/jem.177.6.1541
Abstract
A previous report showed that the proliferative response of helper T cells to class II major histocompatibility complex (MHC)-restricted antigens can be inhibited by analogues of the antigen, which act as T cell receptor (TCR) antagonists. Here we define and analyze peptide variants that antagonize various functions of class I MHC-restricted cytotoxic T lymphocyte (CTL) clones. Of 64 variants at individual TCR contact sites of the Kb-restricted octamer peptide ovalbumin257-264 (OVAp), a very high proportion (40%) antagonized lysis by three OVAp-specific CTL clones. This effect was highly clone specific, since many antagonists for one T cell clone have differential effects on another. We show that this inhibition of CTL function is not a result of T cell-T cell interaction, precluding veto-like phenomena as a mechanism for antagonism. Moreover, we present evidence for direct interaction between the TCR and antagonist-MHC complexes. In further analysis of the T cell response, we found that serine esterase release and cytokine production are susceptible to TCR antagonism similarly to lysis. Ca2+ flux, an early event in signaling, is also inhibited by antagonists but may be more resistant to the antagonist effect than downstream responses.Keywords
This publication has 38 references indexed in Scilit:
- Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.The Journal of Experimental Medicine, 1993
- Antigen recognition by T cells. Quantitative effects of augmentation by antibodies providing accessory interactions.The Journal of Immunology, 1990
- An immunoregulatory function for the CD8 molecule.Proceedings of the National Academy of Sciences, 1989
- T cell receptor beta-chain selection in human allograft rejection.The Journal of Immunology, 1989
- Introduction of soluble protein into the class I pathway of antigen processing and presentationCell, 1988
- Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune interventionCell, 1988
- Veto CellsAnnual Review of Immunology, 1988
- Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry.The Journal of Immunology, 1986
- A novel serine esterase expressed by cytotoxic T lymphocytesNature, 1985
- Growth of factor-dependent hemopoietic precursor cell lines.The Journal of Experimental Medicine, 1980